Medherant Limited
Pharmaceutical Manufacturing • 
Coventry, England, United Kingdom • 11-20 Employees
Company overview
| Headquarters | University of Warwick Science Park, Sir William Lyons Rd, Coventry, CV4 7EZ, GB |
| Phone number | +44206942510 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2015 |
| Employees | 11-20 |
| Socials |
Key Contacts at Medherant Limited
Karolina Afors
Medical Director
John Burt
Chief Executive Officer
Medherant Limited Email Formats
Medherant Limited uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@medherant.co.uk), used 82.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@medherant.co.uk | 82.4% |
{first initial}.{last name} | j.doe@medherant.co.uk | 17.6% |
About Medherant Limited
Medherant is a clinical-stage company developing innovative treatments using its novel transdermal drug delivery technology, the TEPI Patch, which is based on a proprietary adhesive developed by its scientists. The Company was founded by Professor David Haddleton and the University of Warwick in 2015 based on their world-leading expertise in bioadhesives and polymer chemistry. The adhesive has a high drug loading capacity, so a smaller quantity of adhesive is needed to deliver a therapeutic dose; the patch can therefore be thinner and more flexible. It also enables excipients, such as permeation enhancers, to be included in the adhesive so the release of the drug from the patch can be tailored to achieve the desired product profile. The adhesive also provides excellent adhesion, even in moist conditions. This means that the patch remains in contact with the skin throughout the dosing period, so the full dose is delivered. There is no leakage of adhesive from the patch so there is no unsightly black ring around its edge and no residue on the skin after removal. Medherant undertakes feasibility studies for other companies to investigate whether their drugs can be formulated for transdermal delivery using the TEPI technology. Medherant welcomes enquires from companies interested in licensing its products for commercialisation or undertaking feasibility studies.
Medherant Limited revenue & valuation
| Annual revenue | $7,500,000 |
| Revenue per employee | $417,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $24,000,000 |
| Total funding | $3,600,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Medherant Limited has 9 employees across 5 departments.
Departments
Number of employees
Medherant Limited Tech Stack
Discover the technologies and tools that power Medherant Limited's digital infrastructure, from frameworks to analytics platforms.
Web servers
CDN
JavaScript libraries
Tag managers
Hosting
Programming languages
Security
Miscellaneous
Cookie compliance
JavaScript libraries
CMS
Miscellaneous
United States
Australia
Portugal
Spain
CanadaFrequently asked questions
4.8
40,000 users
